InsiderClue
← All stocks

Medpace Holdings, Inc.

MEDP Net selling
CIK 0001668397 #724 in the set updated 21 Sep 2026
Bought (120 mo)
$309.19M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$3.62B
$288.08M on a plan · $135.21M straight out of an exercise
Sold at will
$3.20B
433 of 502 sales
Net
−$3.31B
−$2.89B against sales at will

By person

16 insiders · 606 transactions
6,615×

August J. Troendle holds 6,615 times base salary in stock. $6.20B of shares against $937.42K in salary for 2025.

Salary from the company's own proxy. The shares are what August J. Troendle last reported holding, valued at $621.29, the price Common Stock was last bought or sold at on the open market here, on 16 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Troendle August J.
President & CEO
$154.56M (17)
$1.40B (232)
−$1.25B
9,981,191
35.76%
$6.20B
−34.2%
Medpace Limited Partnership entity
10% owner
—
$998.48M (6)
−$998.48M
0
0.0000%
$0.00
−100.0%
Medpace Investors, LLC entity
10% owner
$154.56M (17)
$999.64M (179)
−$845.08M
4,733,019
16.96%
$2.94B
−48.6%
GEIGER JESSE J
President
—
$83.46M (22) scheduled
−$83.46M
15,000
0.0537%
$9.32M
—
BURWIG SUSAN E
Exec. VP, Operations
—
$61.14M (17)
−$61.14M
65,984
0.2364%
$41.00M
+243.5%
EWALD STEPHEN P
General Counsel & Corp. Secy.
$652.22 (1)
$33.36M (15) scheduled
−$33.36M
20,343
0.0729%
$12.64M
—
Kraft Robert O.
Director
—
$15.18M (6) scheduled
−$15.18M
955
0.0034%
$593.33K
—
Brady Kevin M.
CFO & Treasurer
—
$11.87M (7) scheduled
−$11.87M
12,830
0.0460%
$7.97M
+156.6%
DAVENPORT FRED B JR
Director
$72.90K (1)
$8.41M (3) scheduled
−$8.33M
5,798
0.0208%
$3.60M
+286.5%
Carley Brian T
Director
—
$4.43M (2)
−$4.43M
27,825
0.0997%
$17.29M
—
McCarthy Cornelius P. III
Director
—
$1.93M (3)
−$1.93M
12,275
0.0440%
$7.63M
—
Keating Ashley M.
Director
—
$1.69M (8) scheduled
−$1.69M
250
0.0009%
$155.32K
—
King Tom C
Director
—
$79.60K (2) scheduled
−$79.60K
598
0.0021%
$371.53K
—
Brown Bruce
Director
—
—
—
9,295
0.0333%
$5.77M
—
BUCKNELL PENELOPE J
VP, Human Resources
—
—
—
3,000
0.0107%
$1.86M
—
Fifth Cinven Fund (No. 1) Limited Partnership entity
10% owner
—
—
—
0
0.0000%
$0.00
−100.0%

Individual transactions

250
Insider
Date
Role
Action
Shares
Price
Amount
Troendle August J.
16 Sep 2026
President & CEO
Sell
8,770
$621.29
$5.45M
Troendle August J.
15 Sep 2026
President & CEO
Sell
15,971
$620.84
$9.92M
BURWIG SUSAN E
15 Sep 2026
Exec. VP, Operations
Exercised, kept
3,000
$166.73
$500.19K
Troendle August J.
27 Aug 2026
President & CEO
Sell
650
$620.27
$403.18K
Kraft Robert O.
26 Aug 2026
Director
Sold after exercise
3,858
$617.81
$2.38M
Troendle August J.
26 Aug 2026
President & CEO
Sell
4,000
$620.03
$2.48M
Troendle August J.
25 Aug 2026
President & CEO
Sell
673
$620.38
$417.52K
Troendle August J.
24 Aug 2026
President & CEO
Sell
1,983
$620.23
$1.23M
Troendle August J.
21 Aug 2026
President & CEO
Sell
13,995
$624.45
$8.74M
Brady Kevin M.
20 Aug 2026
CFO & Treasurer
Sold after exercise
3,400
$625.24
$2.13M
Troendle August J.
20 Aug 2026
President & CEO
Sell
27,174
$618.79
$16.81M
DAVENPORT FRED B JR
19 Aug 2026
Director
Sold after exercise
7,283
$606.15
$4.41M
Carley Brian T
19 Aug 2026
Director
Sell
5,000
$608.63
$3.04M
Troendle August J.
19 Aug 2026
President & CEO
Sell
15,609
$606.47
$9.47M
Troendle August J.
13 Aug 2026
President & CEO
Sell
458
$600.39
$274.98K
Troendle August J.
12 Aug 2026
President & CEO
Sell
11,366
$601.53
$6.84M
Troendle August J.
11 Aug 2026
President & CEO
Sell
17,610
$605.11
$10.66M
McCarthy Cornelius P. III
11 Aug 2026
Director
Sell
1,140
$605.37
$690.12K
Troendle August J.
10 Aug 2026
President & CEO
Sell
5,534
$601.53
$3.33M
McCarthy Cornelius P. III
7 Aug 2026
Director
Sold after exercise
795
$585.07
$465.13K
BURWIG SUSAN E
28 Jul 2026
Exec. VP, Operations
Sell
7,500
$600.00
$4.50M
Troendle August J.
28 Jul 2026
President & CEO
Sell
3,510
$600.01
$2.11M
Troendle August J.
27 Jul 2026
President & CEO
Sell
3,728
$600.85
$2.24M
EWALD STEPHEN P
28 May 2026
General Counsel & Corp. Secy.
Sold after exercise
16,349
$450.00
$7.36M
Brady Kevin M.
24 Apr 2026
CFO & Treasurer
Exercised, kept
7,000
$138.87
$972.09K
EWALD STEPHEN P
24 Apr 2026
General Counsel & Corp. Secy.
Exercised, kept
3,500
$138.87
$486.05K
BURWIG SUSAN E
18 Mar 2026
Exec. VP, Operations
Exercised, kept
12,000
$166.73
$2.00M
GEIGER JESSE J
17 Mar 2026
President
Sold after exercise
31,707
$455.30
$14.44M
EWALD STEPHEN P
17 Feb 2026
General Counsel & Corp. Secy.
Exercised, kept
3,500
$138.87
$486.05K
BURWIG SUSAN E
13 Feb 2026
Exec. VP, Operations
Exercised, kept
10,984
$107.93
$1.19M
Carley Brian T
13 Feb 2026
Director
Exercised, kept
6,472
$54.99
$355.90K
BURWIG SUSAN E
5 Dec 2025
Exec. VP, Operations
Exercised, kept
10,000
$107.93
$1.08M
Troendle August J.
3 Dec 2025
CEO
Sell
668
$590.69
$394.58K
Troendle August J.
2 Dec 2025
CEO
Sell
5,698
$590.47
$3.36M
BURWIG SUSAN E
2 Dec 2025
Exec. VP, Operations
Exercised, kept
10,000
$107.93
$1.08M
Troendle August J.
1 Dec 2025
CEO
Sell
23,178
$593.25
$13.75M
Troendle August J.
28 Nov 2025
CEO
Sell
15,151
$593.46
$8.99M
Troendle August J.
26 Nov 2025
CEO
Sell
41,331
$606.88
$25.08M
Troendle August J.
25 Nov 2025
CEO
Sell
42,392
$615.52
$26.09M
BURWIG SUSAN E
24 Nov 2025
Exec. VP, Operations
Sell
20,000
$609.15
$12.18M
Troendle August J.
24 Nov 2025
CEO
Sell
59,025
$607.78
$35.87M
Troendle August J.
21 Nov 2025
CEO
Sell
21,858
$592.18
$12.94M
Brady Kevin M.
21 Nov 2025
CFO & Treasurer
Sold after exercise
3,000
$590.35
$1.77M
Troendle August J.
20 Nov 2025
CEO
Sell
6,830
$598.49
$4.09M
Troendle August J.
19 Nov 2025
CEO
Sell
23,862
$592.07
$14.13M
Troendle August J.
18 Nov 2025
CEO
Sell
7,191
$590.84
$4.25M
Troendle August J.
17 Nov 2025
CEO
Sell
6,047
$591.00
$3.57M
Troendle August J.
14 Nov 2025
CEO
Sell
14,747
$595.26
$8.78M
Kraft Robert O.
14 Nov 2025
Director
Sold after exercise
6,472
$591.85
$3.83M
Troendle August J.
13 Nov 2025
CEO
Sell
5,128
$601.37
$3.08M
Troendle August J.
12 Nov 2025
CEO
Sell
5,312
$603.23
$3.20M
BURWIG SUSAN E
11 Nov 2025
Exec. VP, Operations
Sell
18,000
$605.00
$10.89M
GEIGER JESSE J
5 Nov 2025
President
Sold on a plan
21,503
$595.66
$12.81M
DAVENPORT FRED B JR
30 Oct 2025
Director
Sold after exercise
5,972
$581.88
$3.47M
GEIGER JESSE J
29 Oct 2025
President
Sold after exercise
3,568
$585.00
$2.09M
BURWIG SUSAN E
27 Oct 2025
Exec. VP, Operations
Sell
2,000
$605.01
$1.21M
EWALD STEPHEN P
27 Oct 2025
General Counsel & Corp. Secy.
Sold after exercise
15,230
$598.85
$9.12M
GEIGER JESSE J
27 Oct 2025
President
Sold after exercise
19,460
$605.12
$11.78M
BURWIG SUSAN E
26 Sep 2025
Exec. VP, Operations
Exercised, kept
10,000
$107.93
$1.08M
BURWIG SUSAN E
3 Sep 2025
Exec. VP, Operations
Sell
10,000
$480.00
$4.80M
Troendle August J.
2 Sep 2025
CEO
Sell
1,197
$475.11
$568.71K
Troendle August J.
29 Aug 2025
CEO
Sell
36,196
$475.90
$17.23M
Troendle August J.
27 Aug 2025
CEO
Sell
620
$475.00
$294.50K
BURWIG SUSAN E
26 Aug 2025
Exec. VP, Operations
Exercised, kept
10,000
$107.93
$1.08M
McCarthy Cornelius P. III
19 Aug 2025
Director
Sell
1,662
$465.04
$772.90K
Troendle August J.
28 Jul 2025
CEO
Sell
48,487
$451.69
$21.90M
BURWIG SUSAN E
28 Jul 2025
Exec. VP, Operations
Sell
7,500
$450.14
$3.38M
EWALD STEPHEN P
28 Jul 2025
General Counsel & Corp. Secy.
Sell
3,000
$450.00
$1.35M
Brady Kevin M.
24 Jul 2025
CFO & Treasurer
Sold after exercise
12,000
$454.23
$5.45M
GEIGER JESSE J
24 Jul 2025
President
Sold after exercise
41,801
$453.11
$18.94M
McCarthy Cornelius P. III
22 Jul 2025
Director
Exercised, kept
1,972
$54.99
$108.44K
McCarthy Cornelius P. III
18 Jul 2025
Director
Exercised, kept
4,500
$54.99
$247.46K
DAVENPORT FRED B JR
24 Apr 2025
Director
Sold after exercise
1,712
$301.82
$516.72K
Troendle August J.
7 Mar 2025
CEO
Exercised, kept
84,770
$107.93
$9.15M
Troendle August J.
7 Mar 2025
CEO
Exercised, kept
234,259
$56.61
$13.26M
Troendle August J.
7 Mar 2025
CEO
Exercised, kept
37,417
$54.74
$2.05M
EWALD STEPHEN P
27 Feb 2025
General Counsel & Corp. Secy.
Buy
2
$326.11
$652.22
Carley Brian T
24 Feb 2025
Director
Sold after exercise
4,003
$345.59
$1.38M
GEIGER JESSE J
6 Dec 2024
President
Exercised, kept
15,000
$32.05
$480.75K
BURWIG SUSAN E
19 Nov 2024
Exec. VP, Operations
Exercised, kept
7,500
$32.05
$240.38K
Kraft Robert O.
23 Aug 2024
Director
Sold after exercise
3,774
$390.73
$1.47M
Kraft Robert O.
22 Aug 2024
Director
Sold after exercise
4,353
$390.73
$1.70M
BURWIG SUSAN E
5 Aug 2024
Exec. VP, Operations
Exercised, kept
50,000
$90.65
$4.53M
BURWIG SUSAN E
5 Jun 2024
Exec. VP, Operations
Sell
7,681
$401.20
$3.08M
Troendle August J.
28 May 2024
CEO
Sell
5,695
$395.49
$2.25M
Troendle August J.
24 May 2024
CEO
Sell
3,987
$395.22
$1.58M
Troendle August J.
22 May 2024
CEO
Sell
55
$400.00
$22.00K
Troendle August J.
20 May 2024
CEO
Sell
4,020
$400.19
$1.61M
Troendle August J.
16 May 2024
CEO
Sell
7,060
$403.09
$2.85M
Troendle August J.
15 May 2024
CEO
Sell
32,282
$405.13
$13.08M
Troendle August J.
10 May 2024
CEO
Sell
4,956
$402.89
$2.00M
Troendle August J.
9 May 2024
CEO
Sell
3,486
$400.17
$1.39M
Troendle August J.
8 May 2024
CEO
Sell
4,782
$400.58
$1.92M
Troendle August J.
7 May 2024
CEO
Sell
28,032
$404.48
$11.34M
Troendle August J.
6 May 2024
CEO
Sell
24,372
$401.73
$9.79M
Troendle August J.
2 May 2024
CEO
Sell
3,396
$400.44
$1.36M
Troendle August J.
1 May 2024
CEO
Sell
12,934
$401.56
$5.19M
Troendle August J.
30 Apr 2024
CEO
Sell
1,828
$400.31
$731.77K
Troendle August J.
29 Apr 2024
CEO
Sell
15,102
$400.69
$6.05M
BURWIG SUSAN E
15 Mar 2024
Exec. VP, Operations
Sell
102
$403.00
$41.11K
Keating Ashley M.
14 Mar 2024
Director
Sold after exercise
250
$409.87
$102.47K
Medpace Investors, LLC
8 Mar 2024
10% owner
Sell
25,000
$408.71
$10.22M
Troendle August J.
8 Mar 2024
CEO
Sell indirect
25,000
$408.71
$10.22M
Keating Ashley M.
7 Mar 2024
Director
Sold after exercise
472
$415.00
$195.88K
Medpace Investors, LLC
7 Mar 2024
10% owner
Sell
75,000
$410.74
$30.81M
Troendle August J.
7 Mar 2024
CEO
Sell indirect
75,000
$410.74
$30.81M
Medpace Investors, LLC
6 Mar 2024
10% owner
Sell
100,000
$412.98
$41.30M
Troendle August J.
6 Mar 2024
CEO
Sell indirect
100,000
$412.98
$41.30M
Medpace Investors, LLC
5 Mar 2024
10% owner
Sell
50,000
$402.70
$20.14M
Troendle August J.
5 Mar 2024
CEO
Sell indirect
50,000
$402.70
$20.14M
GEIGER JESSE J
5 Mar 2024
President
Exercised, kept
17,679
$90.65
$1.60M
Medpace Investors, LLC
4 Mar 2024
10% owner
Sell
50,000
$403.12
$20.16M
Troendle August J.
4 Mar 2024
CEO
Sell indirect
50,000
$403.12
$20.16M
GEIGER JESSE J
4 Mar 2024
President
Sold after exercise
22,321
$403.03
$9.00M
EWALD STEPHEN P
1 Mar 2024
General Counsel & Corp. Secy.
Sell
350
$400.79
$140.28K
Troendle August J.
1 Mar 2024
CEO
Sell indirect
80,000
$401.88
$32.15M
Medpace Investors, LLC
1 Mar 2024
10% owner
Sell
80,000
$401.88
$32.15M
GEIGER JESSE J
29 Feb 2024
President
Sell
2,558
$393.51
$1.01M
EWALD STEPHEN P
29 Feb 2024
General Counsel & Corp. Secy.
Sell
1,163
$393.51
$457.65K
Troendle August J.
29 Feb 2024
CEO
Sell indirect
20,000
$393.71
$7.87M
Medpace Investors, LLC
29 Feb 2024
10% owner
Sell
20,000
$393.71
$7.87M
Medpace Investors, LLC
28 Feb 2024
10% owner
Sell
50,000
$404.13
$20.21M
Troendle August J.
28 Feb 2024
CEO
Sell indirect
50,000
$404.13
$20.21M
Keating Ashley M.
28 Feb 2024
Director
Sold after exercise
500
$405.00
$202.50K
Medpace Investors, LLC
27 Feb 2024
10% owner
Sell
50,000
$401.88
$20.09M
Troendle August J.
27 Feb 2024
CEO
Sell indirect
50,000
$401.88
$20.09M
Medpace Investors, LLC
26 Feb 2024
10% owner
Sell
56,928
$402.38
$22.91M
Troendle August J.
26 Feb 2024
CEO
Sell indirect
56,928
$402.38
$22.91M
Keating Ashley M.
26 Feb 2024
Director
Sold after exercise
254
$404.68
$102.79K
Keating Ashley M.
26 Feb 2024
Director
Sold after exercise
246
$403.89
$99.36K
Medpace Investors, LLC
23 Feb 2024
10% owner
Sell
100,000
$400.32
$40.03M
Troendle August J.
23 Feb 2024
CEO
Sell indirect
100,000
$400.32
$40.03M
Troendle August J.
22 Feb 2024
CEO
Sell indirect
100,000
$395.98
$39.60M
Medpace Investors, LLC
22 Feb 2024
10% owner
Sell
100,000
$395.98
$39.60M
Troendle August J.
21 Feb 2024
CEO
Sell indirect
36,012
$383.44
$13.81M
Medpace Investors, LLC
21 Feb 2024
10% owner
Sell
36,012
$383.44
$13.81M
Troendle August J.
20 Feb 2024
CEO
Sell indirect
13,988
$386.39
$5.40M
Medpace Investors, LLC
20 Feb 2024
10% owner
Sell
13,988
$386.39
$5.40M
Carley Brian T
20 Feb 2024
Director
Exercised, kept
13,782
$26.44
$364.40K
Troendle August J.
16 Feb 2024
CEO
Sell indirect
50,000
$391.75
$19.59M
Medpace Investors, LLC
16 Feb 2024
10% owner
Sell
50,000
$391.75
$19.59M
McCarthy Cornelius P. III
8 Feb 2024
Director
Exercised, kept
4,710
$57.17
$269.27K
BURWIG SUSAN E
15 Dec 2023
Exec. VP, Operations
Sell
2,009
$303.00
$608.73K
BURWIG SUSAN E
14 Dec 2023
Exec. VP, Operations
Sell
10,391
$304.15
$3.16M
Medpace Investors, LLC
1 Dec 2023
10% owner
Sell
24,039
$273.26
$6.57M
Troendle August J.
1 Dec 2023
CEO
Sell indirect
24,039
$273.26
$6.57M
Medpace Investors, LLC
30 Nov 2023
10% owner
Sell
7,871
$272.18
$2.14M
Troendle August J.
30 Nov 2023
CEO
Sell indirect
7,871
$272.18
$2.14M
Medpace Investors, LLC
29 Nov 2023
10% owner
Sell
18,090
$272.62
$4.93M
Medpace Investors, LLC
29 Nov 2023
10% owner
Sell
3,167
$272.87
$864.18K
Troendle August J.
29 Nov 2023
CEO
Sell indirect
18,090
$272.62
$4.93M
Troendle August J.
29 Nov 2023
CEO
Sell indirect
3,167
$272.87
$864.18K
Troendle August J.
28 Nov 2023
CEO
Sell indirect
21,833
$273.66
$5.97M
Medpace Investors, LLC
28 Nov 2023
10% owner
Sell
21,833
$273.66
$5.97M
Troendle August J.
27 Nov 2023
CEO
Sell indirect
25,000
$276.10
$6.90M
Medpace Investors, LLC
27 Nov 2023
10% owner
Sell
25,000
$276.10
$6.90M
Medpace Investors, LLC
22 Nov 2023
10% owner
Sell
25,000
$277.81
$6.95M
Troendle August J.
22 Nov 2023
CEO
Sell indirect
25,000
$277.81
$6.95M
Troendle August J.
21 Nov 2023
CEO
Sell indirect
25,000
$277.37
$6.93M
Medpace Investors, LLC
21 Nov 2023
10% owner
Sell
25,000
$277.37
$6.93M
Troendle August J.
20 Nov 2023
CEO
Sell indirect
50,000
$275.45
$13.77M
Medpace Investors, LLC
20 Nov 2023
10% owner
Sell
50,000
$275.45
$13.77M
Troendle August J.
17 Nov 2023
CEO
Sell indirect
50,000
$273.91
$13.70M
Medpace Investors, LLC
17 Nov 2023
10% owner
Sell
50,000
$273.91
$13.70M
Medpace Investors, LLC
16 Nov 2023
10% owner
Sell
17,000
$281.61
$4.79M
Troendle August J.
16 Nov 2023
CEO
Sell indirect
17,000
$281.61
$4.79M
Medpace Investors, LLC
15 Nov 2023
10% owner
Sell
33,000
$283.42
$9.35M
Troendle August J.
15 Nov 2023
CEO
Sell indirect
33,000
$283.42
$9.35M
Medpace Investors, LLC
14 Nov 2023
10% owner
Sell
25,000
$283.11
$7.08M
Troendle August J.
14 Nov 2023
CEO
Sell indirect
25,000
$283.11
$7.08M
BURWIG SUSAN E
23 Oct 2023
Exec. VP, Operations
Exercised, kept
7,500
$32.05
$240.38K
Medpace Investors, LLC
21 Sep 2023
10% owner
Sold on a plan
61,655
$244.27
$15.06M
Troendle August J.
21 Sep 2023
CEO
Sold on a plan indirect
61,655
$244.27
$15.06M
Medpace Investors, LLC
20 Sep 2023
10% owner
Sold on a plan
65,653
$255.48
$16.77M
Troendle August J.
20 Sep 2023
CEO
Sold on a plan indirect
65,653
$255.48
$16.77M
Troendle August J.
19 Sep 2023
CEO
Sold on a plan indirect
137,379
$259.66
$35.67M
Medpace Investors, LLC
19 Sep 2023
10% owner
Sold on a plan
137,379
$259.66
$35.67M
Troendle August J.
18 Sep 2023
CEO
Sold on a plan indirect
53,385
$274.76
$14.67M
Medpace Investors, LLC
18 Sep 2023
10% owner
Sold on a plan
53,385
$274.76
$14.67M
Kraft Robert O.
14 Aug 2023
Director
Sold after exercise
13,782
$265.67
$3.66M
Brady Kevin M.
31 Jul 2023
CFO & Treasurer
Sold after exercise
7,000
$255.00
$1.79M
EWALD STEPHEN P
27 Jul 2023
General Counsel & Corp. Secy.
Sold after exercise
21,850
$254.39
$5.56M
Carley Brian T
15 Jun 2023
Director
Exercised, kept
7,400
$23.00
$170.20K
Medpace Investors, LLC
8 Jun 2023
10% owner
Sold on a plan
49,347
$220.85
$10.90M
Troendle August J.
8 Jun 2023
CEO
Sold on a plan indirect
49,347
$220.85
$10.90M
Medpace Investors, LLC
7 Jun 2023
10% owner
Sold on a plan
110,324
$223.05
$24.61M
Troendle August J.
7 Jun 2023
CEO
Sold on a plan indirect
110,324
$223.05
$24.61M
Medpace Investors, LLC
6 Jun 2023
10% owner
Sold on a plan
58,681
$220.46
$12.94M
Troendle August J.
6 Jun 2023
CEO
Sold on a plan indirect
58,681
$220.46
$12.94M
Medpace Investors, LLC
25 Apr 2023
10% owner
Sold on a plan
31,648
$221.83
$7.02M
Troendle August J.
25 Apr 2023
CEO
Sold on a plan indirect
31,648
$221.83
$7.02M
Brady Kevin M.
16 Nov 2022
CFO & Treasurer
Sell
344
$227.09
$78.12K
GEIGER JESSE J
15 Nov 2022
President
Sold after exercise
7,000
$230.00
$1.61M
Brady Kevin M.
15 Nov 2022
CFO & Treasurer
Sell
1,656
$229.30
$379.72K
Kraft Robert O.
1 Nov 2022
Director
Sold after exercise
9,630
$221.42
$2.13M
EWALD STEPHEN P
27 Oct 2022
General Counsel & Corp. Secy.
Sold after exercise
6,500
$220.53
$1.43M
Troendle August J.
22 Sep 2022
CEO
Buy indirect
57,426
$154.59
$8.88M
Medpace Investors, LLC
22 Sep 2022
10% owner
Buy
57,426
$154.59
$8.88M
Medpace Investors, LLC
21 Sep 2022
10% owner
Buy
94,119
$161.63
$15.21M
Troendle August J.
21 Sep 2022
CEO
Buy indirect
94,119
$161.63
$15.21M
Medpace Investors, LLC
20 Sep 2022
10% owner
Buy
94,119
$155.14
$14.60M
Troendle August J.
20 Sep 2022
CEO
Buy indirect
94,119
$155.14
$14.60M
Troendle August J.
19 Sep 2022
CEO
Buy indirect
94,119
$153.48
$14.45M
Medpace Investors, LLC
19 Sep 2022
10% owner
Buy
94,119
$153.48
$14.45M
Troendle August J.
16 Sep 2022
CEO
Buy indirect
62,516
$149.58
$9.35M
Medpace Investors, LLC
16 Sep 2022
10% owner
Buy
62,516
$149.58
$9.35M
Medpace Investors, LLC
15 Sep 2022
10% owner
Buy
62,516
$153.11
$9.57M
Troendle August J.
15 Sep 2022
CEO
Buy indirect
62,516
$153.11
$9.57M
Medpace Investors, LLC
14 Sep 2022
10% owner
Buy
62,516
$152.66
$9.54M
Troendle August J.
14 Sep 2022
CEO
Buy indirect
62,516
$152.66
$9.54M
Medpace Investors, LLC
13 Sep 2022
10% owner
Buy
62,516
$157.12
$9.82M
Troendle August J.
13 Sep 2022
CEO
Buy indirect
62,516
$157.12
$9.82M
Medpace Investors, LLC
12 Sep 2022
10% owner
Buy
62,515
$167.58
$10.48M
Troendle August J.
12 Sep 2022
CEO
Buy indirect
62,515
$167.58
$10.48M
Medpace Investors, LLC
9 Sep 2022
10% owner
Buy
56,557
$164.33
$9.29M
Troendle August J.
9 Sep 2022
CEO
Buy indirect
56,557
$164.33
$9.29M
Medpace Investors, LLC
8 Sep 2022
10% owner
Buy
56,557
$157.65
$8.92M
Troendle August J.
8 Sep 2022
CEO
Buy indirect
56,557
$157.65
$8.92M
Troendle August J.
7 Sep 2022
CEO
Buy indirect
56,557
$150.72
$8.52M
Medpace Investors, LLC
7 Sep 2022
10% owner
Buy
56,557
$150.72
$8.52M
Troendle August J.
6 Sep 2022
CEO
Buy indirect
56,557
$147.59
$8.35M
Medpace Investors, LLC
6 Sep 2022
10% owner
Buy
56,557
$147.59
$8.35M
Troendle August J.
2 Sep 2022
CEO
Buy indirect
48,714
$144.98
$7.06M
Medpace Investors, LLC
2 Sep 2022
10% owner
Buy
48,714
$144.98
$7.06M
Troendle August J.
1 Sep 2022
CEO
Buy indirect
42,076
$144.52
$6.08M
Medpace Investors, LLC
1 Sep 2022
10% owner
Buy
42,076
$144.52
$6.08M
Medpace Investors, LLC
18 Jul 2022
10% owner
Buy
8,330
$145.00
$1.21M
Troendle August J.
18 Jul 2022
CEO
Buy indirect
8,330
$145.00
$1.21M
Medpace Investors, LLC
14 Jul 2022
10% owner
Buy
22,290
$144.59
$3.22M
Troendle August J.
14 Jul 2022
CEO
Buy indirect
22,290
$144.59
$3.22M
EWALD STEPHEN P
6 May 2022
General Counsel & Corp. Secy.
Exercised, kept
1,000
$32.05
$32.05K
Troendle August J.
1 Mar 2022
CEO
Exercised, kept
100,000
$90.65
$9.07M
BURWIG SUSAN E
23 Feb 2022
Exec. VP, Operations
Exercised, kept
12,400
$28.32
$351.17K
DAVENPORT FRED B JR
17 Feb 2022
Director
Buy indirect
500
$145.80
$72.90K
Medpace Investors, LLC
4 Jan 2022
10% owner
Sell
3,338
$213.44
$712.46K
Troendle August J.
4 Jan 2022
CEO
Sell indirect
3,338
$213.44
$712.46K
Medpace Investors, LLC
3 Jan 2022
10% owner
Sell
19,744
$212.70
$4.20M
Troendle August J.
3 Jan 2022
CEO
Sell indirect
19,744
$212.70
$4.20M
Medpace Investors, LLC
31 Dec 2021
10% owner
Sell
13,069
$219.14
$2.86M
Troendle August J.
31 Dec 2021
CEO
Sell indirect
13,069
$219.14
$2.86M
Medpace Investors, LLC
30 Dec 2021
10% owner
Sell
17,376
$220.34
$3.83M
Troendle August J.
30 Dec 2021
CEO
Sell indirect
17,376
$220.34
$3.83M
Medpace Investors, LLC
29 Dec 2021
10% owner
Sell
16,750
$220.16
$3.69M
Troendle August J.
29 Dec 2021
CEO
Sell indirect
16,750
$220.16
$3.69M
Medpace Investors, LLC
28 Dec 2021
10% owner
Sell
24,118
$222.18
$5.36M
Troendle August J.
28 Dec 2021
CEO
Sell indirect
24,118
$222.18
$5.36M
Medpace Investors, LLC
27 Dec 2021
10% owner
Sell
39,171
$226.11
$8.86M
Troendle August J.
27 Dec 2021
CEO
Sell indirect
39,171
$226.11
$8.86M
Medpace Investors, LLC
23 Dec 2021
10% owner
Sell
22,830
$223.19
$5.10M
Troendle August J.
23 Dec 2021
CEO
Sell indirect
22,830
$223.19
$5.10M
Showing 250 of 606 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 523
Amendments (4/A) skipped 7
Filings about a different issuer 0
Unreadable filings 0
Joint filings 7
Sales on a Rule 10b5-1 plan 17
Sales straight out of an exercise 52
Sales at will 433
Transactions with no price 0
Shares from compensation/vesting 26,764,827
Sales filed before the plan box existed 311
History held since 3 Nov 2016